The stable outlook reflects S&P Global Ratings’ expectation that Amgen’s revenue and EBITDA will remain stable despite patent ...

Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium ...

Shares of Regeneron Pharmaceuticals Inc. slipped 3.63% to $527.78 Friday, on what proved to be an all-around poor trading ...

The Dow Jones Industrial Average is trading down Friday afternoon with shares of UnitedHealth and IBM seeing the biggest losses for the price-weighted average. The Dow was most recently trading 217 ...